Genetic correction of X-linked chronic granulomatous disease with novel foamy virus vectors

Foamy virus vectors expressing the human gp91phox transgene constitute potential candidates for the gene therapy of CGD because they combine lack of pathogenicity with efficacy even at low MOI.